Indegene Ltd (BOM:544172)

Q1 2027 Indegene Ltd Earnings Call Transcript

Jul 30, 2026 / 03:30 AM GMT

Release Date Price: ₹514.6 (+0.02%)

Transcript

Key Points

Positve

Indegene Ltd (NSE:INDGN) reported strong Q1 FY27 revenue of INR10,631 million, up 39.7% year-on-year and 6% quarter-on-quarter, marking the best first-quarter sequential growth in four years.
The company's client base crossed a milestone of 100 active customers, reaching 105, with revenue from accounts beyond the TOP20 now contributing over a third of total revenue, indicating successful diversification.
Revenue per employee reached approximately $77,000 on a trailing twelve-month basis, which management highlighted as industry-leading and a reflection of the productivity of its engagement model.
The company signed several strategic deals, including an expansion of the Tectonic engagement to Spain and a $10 million+ outcome-based omnichannel marketing deal with a top customer, which is expected to contribute to revenue starting Q3 FY27.
Management reiterated confidence in margin recovery, expecting EBITDA to return to the historical 19%-20% range by Q4 FY27, driven by revenue ramp-up from contracted deals and productivity benefits from workforce transformation and GenAI initiatives.
The company highlighted its 'Indegene Edge' (Embedded revenue partner, Domain expertise, GenAI disruptor, Engagement model), positioning it as structurally different from traditional IT services or agencies and resilient to cost-cutting.
Cash and cash equivalents combined with investments remained strong at INR14,602 million, and the company has strengthened its cash position by over 30% in the last two years.

Negative

EBITDA margin declined sequentially when adjusted for the prior quarter's one-time mark-to-market impact, due to investments in workforce transformation and costs related to contracted Tectonic and GenAI engagements where revenue contribution is still building slowly.
The company is carrying costs for the large outcome-based omnichannel engagement since Q4 FY26, with revenue recognition deferred until Q3 FY27, which will continue to pressure margins in the near term.
DSO (days sales outstanding) increased by four days quarter-on-quarter to 67 days, indicating a slight deterioration in receivables collection.
Enterprise adoption of AI remains measured and slower than the enthusiasm suggests, with the Tectonic engagement's offtake on existing scope being described as 'measured', indicating potential delays in revenue ramp-up.
The company faces ongoing risks from currency volatility, with undesignated hedges still material through December of this year, which could impact financial results despite moving to hedge accounting.
Management noted that smaller biotechs had a mixed first half, with funding and IPO conditions remaining selective, which could impact growth in that segment of the customer base.
The company is not breaking out organic vs. inorganic growth or AI-led platform revenue, making it difficult for investors to quantify the impact of specific strategic initiatives.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

INEG.NS - Indegene Ltd
Q1 2027 Indegene Ltd Earnings Call
Jul 31, 2026 / 03:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the Indigene Limited Q1 FY27 earnings conference call.

As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during this conference call, please signal an operator by pressing then 0 on your touch tone phone.

Please note that this conference is being recorded.

I now hand the conference over to Mr. Abhishek Agarwal, Head of Investor Relations, Indigene Limited.

Thank you and over to you, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-----------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.